Back to Results
First PageMeta Content
Finance / Genmab / Investment / Vaccine / Venture capital / Rothschild family / Edmond de Rothschild Group / Business / Sofinnova / GlaxoSmithKline


GlycoVaxyn AG sells its shares to GSK GSK, who was already a minority shareholder in GlycoVaxyn, acquires the company and its biological conjugation platform which may help it to develop a new generation of prophylactic
Add to Reading List

Document Date: 2015-02-11 03:15:17


Open Document

File Size: 40,53 KB

Share Result on Facebook
UPDATE